121 related articles for article (PubMed ID: 15467913)
1. Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): implications for vascular inflammation.
Peerschke EI; Petrovan RJ; Ghebrehiwet B; Ruf W
Thromb Haemost; 2004 Oct; 92(4):811-9. PubMed ID: 15467913
[TBL] [Abstract][Full Text] [Related]
2. gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation.
Ghebrehiwet B; CebadaMora C; Tantral L; Jesty J; Peerschke EI
Adv Exp Med Biol; 2006; 586():95-105. PubMed ID: 16893067
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells.
Joseph K; Ghebrehiwet B; Kaplan AP
Clin Immunol; 1999 Sep; 92(3):246-55. PubMed ID: 10479529
[TBL] [Abstract][Full Text] [Related]
4. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).
Pixley RA; Espinola RG; Ghebrehiwet B; Joseph K; Kao A; Bdeir K; Cines DB; Colman RW
Thromb Haemost; 2011 Jun; 105(6):1053-9. PubMed ID: 21544310
[TBL] [Abstract][Full Text] [Related]
5. The multiligand-binding protein gC1qR, putative C1q receptor, is a mitochondrial protein.
Dedio J; Jahnen-Dechent W; Bachmann M; Müller-Esterl W
J Immunol; 1998 Apr; 160(7):3534-42. PubMed ID: 9531316
[TBL] [Abstract][Full Text] [Related]
6. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
8. Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1.
Joseph K; Shibayama Y; Ghebrehiwet B; Kaplan AP
Thromb Haemost; 2001 Jan; 85(1):119-24. PubMed ID: 11204562
[TBL] [Abstract][Full Text] [Related]
9. The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)
Ghebrehiwet B; Geisbrecht BV; Xu X; Savitt AG; Peerschke EIB
Semin Immunol; 2019 Oct; 45():101338. PubMed ID: 31744753
[TBL] [Abstract][Full Text] [Related]
10. High molecular weight kininogen and factor XII binding to endothelial cells and astrocytes.
Fernando LP; Natesan S; Joseph K; Kaplan AP
Thromb Haemost; 2003 Nov; 90(5):787-95. PubMed ID: 14597972
[TBL] [Abstract][Full Text] [Related]
11. Interaction of high molecular weight kininogen binding proteins on endothelial cells.
Joseph K; Tholanikunnel BG; Ghebrehiwet B; Kaplan AP
Thromb Haemost; 2004 Jan; 91(1):61-70. PubMed ID: 14691569
[TBL] [Abstract][Full Text] [Related]
12. The contribution of gC1qR/p33 in infection and inflammation.
Peerschke EI; Ghebrehiwet B
Immunobiology; 2007; 212(4-5):333-42. PubMed ID: 17544818
[TBL] [Abstract][Full Text] [Related]
13. Activation-dependent surface expression of gC1qR/p33 on human blood platelets.
Peerschke EI; Murphy TK; Ghebrehiwet B
Thromb Haemost; 2003 Feb; 89(2):331-9. PubMed ID: 12574814
[TBL] [Abstract][Full Text] [Related]
14. The soluble recombinant form of a binding protein/receptor for the globular domain of C1q (gC1qR) enhances blood coagulation.
Peerschke EI; Jesty J; Reid KB; Ghebrehiwet B
Blood Coagul Fibrinolysis; 1998 Jan; 9(1):29-37. PubMed ID: 9607116
[TBL] [Abstract][Full Text] [Related]
15. The plasma bradykinin-forming pathways and its interrelationships with complement.
Kaplan AP; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
[TBL] [Abstract][Full Text] [Related]
16. Human umbilical vein endothelial cells possess binding sites for the globular domain of C1q.
Peerschke EI; Smyth SS; Teng EI; Dalzell M; Ghebrehiwet B
J Immunol; 1996 Nov; 157(9):4154-8. PubMed ID: 8892652
[TBL] [Abstract][Full Text] [Related]
17. Globular C1q receptor (p33) binds and stabilizes pro-inflammatory MCP-1: a novel mechanism for regulation of MCP-1 production and function.
Anders E; Nebel D; Westman J; Herwald H; Nilsson BO; Svensson D
Biochem J; 2018 Feb; 475(4):775-786. PubMed ID: 29358188
[TBL] [Abstract][Full Text] [Related]
18. Activation of the plasma kinin forming cascade along cell surfaces.
Kaplan AP; Joseph K; Shibayama Y; Reddigari S; Ghebrehiwet B
Int Arch Allergy Immunol; 2001; 124(1-3):339-42. PubMed ID: 11307009
[TBL] [Abstract][Full Text] [Related]
19. Targeting gC1qR domains for therapy against infection and inflammation.
Ghebrehiwet B; Jesty J; Vinayagasundaram R; Vinayagasundaram U; Ji Y; Valentino A; Tumma N; Hosszu KH; Peerschke EI
Adv Exp Med Biol; 2013; 735():97-110. PubMed ID: 23402021
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus protein A recognizes platelet gC1qR/p33: a novel mechanism for staphylococcal interactions with platelets.
Nguyen T; Ghebrehiwet B; Peerschke EI
Infect Immun; 2000 Apr; 68(4):2061-8. PubMed ID: 10722602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
